FierceBiotech 30. Jan. 2026 Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
FierceBiotech 13. Jan. 2026 JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study
FierceBiotech 6. Jan. 2026 Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
Endpoints News 12. Dez. 2025 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
FierceBiotech 11. Dez. 2025 Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx
Endpoints News 11. Dez. 2025 Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO
Lonza News 7. Okt. 2025 Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire #Therapeutic Innovations #Forecast Report
Cytiva (Google News) 28. Mai 2025 Cytiva Subsidiary Seeks to Quash Subpoena Issued in Amgen’s US Denosumab Litigation Against Accord & Intas - Pearce IP #Subsidiary Seeks #Quash Subpoena